scholarly journals P490 Drug survival and immunogenicity after switching from Remicade® to biosimilar CT-P13 in inflammatory bowel disease patients: Two-year follow-up of a prospective observational cohort study

2018 ◽  
Vol 12 (supplement_1) ◽  
pp. S353-S353
Author(s):  
L Smits ◽  
L Derikx ◽  
A van Esch ◽  
J Drenth ◽  
R Boshuizen ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Cohort Study ◽  
Bowel Disease ◽  
Observational Cohort Study ◽  
Prospective Observational Cohort Study ◽  
Drug Survival ◽  
Observational Cohort ◽  
Inflammatory Bowel

Mo1884 - Drug Survival of Vedolizumab-Treated Inflammatory Bowel Disease Patients in a Nationwide Observational Cohort Study: ICC Case Series

2018 ◽  
Vol 154 (6) ◽  
pp. S-838
Author(s):  
Vince Biemans ◽  
Christien Janneke Van Der Woude ◽  
Gerard Dijkstra ◽  
Andrea Van Der Meulen ◽  
Bas Oldenburg ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Cohort Study ◽  
Bowel Disease ◽  
Case Series ◽  
Observational Cohort Study ◽  
Drug Survival ◽  
Observational Cohort ◽  
Inflammatory Bowel
Sign in / Sign up

Export Citation Format

Share Document